Search

Roche Holding AG

Ouvert

SecteurSoins de santé

279

Résumé

Variation du prix de l'action

24h

Actuel

Min

273.4

Max

280

Chiffres clés

By Trading Economics

Revenu

6.3B

Ventes

31B

P/E

Moyenne du Secteur

26.169

57.333

Rendement du dividende

3.6

Marge bénéficiaire

20.347

Employés

103,249

EBITDA

11B

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.60%

2.63%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

205B

Ouverture précédente

279

Clôture précédente

279

Roche Holding AG Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 avr. 2025, 07:30 UTC

Résultats

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 avr. 2025, 05:31 UTC

Résultats

Roche Sales Rise Boosted By Key Drugs

9 avr. 2025, 09:39 UTC

Principaux Mouvements du Marché

Pharma Stocks Tumble After Trump Threatens Tariffs on Medicines

12 mars 2025, 09:23 UTC

Principaux Mouvements du Marché

Zealand Pharma Shares Leap After Weight-Loss Licensing Deal With Roche

30 janv. 2025, 09:36 UTC

Résultats

Roche Expects Growth to Continue This Year After Sales, Earnings Beat Forecasts -- Update

30 janv. 2025, 06:32 UTC

Résultats

Roche Expects Sales, Earnings Growth After Better-Than-Expected Results

24 avr. 2025, 09:39 UTC

Market Talk
Résultats

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 avr. 2025, 09:24 UTC

Market Talk
Résultats

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 avr. 2025, 09:18 UTC

Market Talk
Résultats

Roche's Results Are Solid -- Market Talk

24 avr. 2025, 05:16 UTC

Actualités

Roche Sales Rise, Boosted By Key Drugs

22 avr. 2025, 10:51 UTC

Actualités

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 avr. 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

9 avr. 2025, 10:03 UTC

Market Talk
Résultats

Roche's Eye Drug in Focus for 1Q Earnings -- Market Talk

9 avr. 2025, 07:23 UTC

Market Talk

Pharma Stocks Tumble After Trump Floats Tariffs on Industry -- Market Talk

3 avr. 2025, 08:41 UTC

Market Talk

Big Pharma Left Uncertain About U.S. Tariff Risk -- Market Talk

3 avr. 2025, 07:51 UTC

Market Talk

Big Pharma Stocks Rise After Exclusion From U.S. Tariffs -- Market Talk

31 mars 2025, 09:31 UTC

Actions en Tendance

Stocks to Watch Monday: Nvidia, Tesla, Robinhood, Tokyo Electron -- WSJ

13 mars 2025, 07:46 UTC

Market Talk

Roche's Zealand Pharma Deal Signals Commitment to Obesity Drug Market -- Market Talk

12 mars 2025, 16:34 UTC

Actualités

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal -- Update

12 mars 2025, 08:51 UTC

Market Talk

Roche's Multiple-Sclerosis Drug Sales Potential Fuels Rating Upgrade -- Market Talk

12 mars 2025, 08:18 UTC

Market Talk

Roche's Obesity Deal With Zealand Pharma Makes Sense, Vontobel Says -- Market Talk

13 févr. 2025, 11:43 UTC

Market Talk

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

30 janv. 2025, 07:56 UTC

Market Talk
Résultats

Roche Delivered Solid Results But Diagnostics' Profitability Disappoints -- Market Talk

30 janv. 2025, 06:04 UTC

Résultats

Roche Expects 2025 EPS Growth in High Single Digit Range at Constant Currency

30 janv. 2025, 06:04 UTC

Résultats

Roche Expects 2025 Sales Increase in Mid Single Digit Range at Constant Currency

30 janv. 2025, 06:04 UTC

Résultats

Roche Issues 2025 View

30 janv. 2025, 06:03 UTC

Résultats

Roche Raises Dividend to CHF9.70 Vs CHF9.60

30 janv. 2025, 06:03 UTC

Résultats

Roche 2024 Core Operating Profit CHF20.82B

30 janv. 2025, 06:03 UTC

Résultats

Roche 2024 Net Pft CHF9.19B

30 janv. 2025, 06:02 UTC

Résultats

Analysts Saw 2024 Core EPS at CHF18.59

Roche Holding AG prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.